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SUMMARY
To identify the clinical and epidemiological profile of cryptococcosis diagnosed at the University Hospital of the Federal
University of Mato Grosso do Sul, Brazil, medical records of 123 patients admitted from January 1995 to December 2005 were
analyzed. One hundred and four cases (84.5%) had HIV infection, six (4.9%) had other predisposing conditions and 13 (10.6%)
were immunocompetent. Male patients predominated (68.3%) and their age ranged from 19 to 69 years (mean: 35.9). Most
patients (73.2%) were born and lived lifelong in the state of Mato Grosso do Sul. Involvement of the central nervous system
occurred in 103 patients (83.7%) and headache and vomiting were the most frequent symptoms. In 77 cases it was possible to
identify the Cryptococcus species: 69 (89.6%) C. neoformans and eight (10.4%) C. gattii. Amphotericin B was the drug of choice
for treatment (106/123), followed by fluconazole in 60% of cases. The overall lethality rate was 49.6%, being 51% among the HIV
infected patients and 41.2% among the non-HIV infected (p > 0.05). Although cryptococcosis exhibited in our region a similar
behavior to that described in the literature, the detection of an important rate of immunocompetent individuals and five C. gattii
cryptococcosis in HIV-infected patients is noteworthy.
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INTRODUCTION
Cryptococcosis is an important opportunistic systemic mycosis
affecting mainly patients with the acquired immunodeficiency
syndrome (AIDS). The disease is caused by two species of the
Cryptococcus neoformans complex, C. neoformans (serotypes A, D,
and AD) and C. gattii (serotypes B and C). The latter, previously
regarded as a variety of C. neoformans, has now gained full species
status1,2. Usually present in urban pigeon droppings, C. neoformans
has a worldwide distribution and is a common opportunistic infection,
whereas C. gattii can be found in hollow trees, usually causes the disease
in non-immunocompromised individuals and behaves as a primary
pathogen3,4. The mycosis is acquired by inhalation of viable propagules
of this agent, causing a pulmonary infection from which it can spread
to other organs, particularly the central nervous system5,6. The paucity
of data on human cryptococcosis in the Brazilian central-western state
of Mato Grosso do Sul encouraged us to carry out the present study.
MATERIALS AND METHODS
The study was performed at the University Hospital of the Federal
University of Mato Grosso do Sul, a reference center for infectious
diseases, analyzing the records of patients diagnosed with
cryptococcosis from January 1995 to December 2005.
The diagnosis of cryptococcosis was based on cerebrospinal fluid
(CSF) direct microscopy with India ink and/or isolation of the fungus
in culture. The C. neoformans complex was identified by the observation
of dark brown yeast colonies after cultivating the suspected yeast on
Niger seed agar (NSA) medium and the species was identified in
canavanine–glycine–bromothymol blue (CGB) medium11.
Demographic, clinical, and laboratory data were recorded in a
specific data bank and the analysis was performed with the Epi Info
3.32 program. Student’s t test was applied to identify differences
between means and the chi-squared test was used for differences
between proportions, with Fisher’s test being applied when the expected
value was less than 5. A significance level of 0.05 was adopted.
The study was approved by the Research Ethics Committee of
UFMS.
RESULTS
During the eleven years period (1995-2005), 123 cases of
cryptococcosis were recorded. Out of them, 104 (84.5%) were HIV
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infected. Of the 19 (15.4%) patients without HIV infection, six had
other predisposing conditions: systemic lupus erythematosus (two
cases), neoplasia (two cases), kidney transplant (one case), and
tuberculous pericarditis treated with prednisone (one case). Fig. 1 shows
the distribution of the cases per year according to HIV infection.
Eighty-four patients (68.3%) were male, 39 (31.7%) were female,
and their ages ranged from 19 to 69 years old, with a mean of 35.9
years. No significant difference in mean age was found between groups
with and without HIV infection.
Most patients (88, or 71.5%) were born in counties located in the
state of Mato Grosso do Sul and 35 (28.4%) elsewhere, of whom 15
(12.2%) were from the Southeastern region, eight (6.5%) from the
Northeastern region, four (3.3%) from the Southern region, and six
(4.9%) came from other Center-Western states. For two patients this
information was not available. Most patients (120; 97.6%) had been
referred from localities in Mato Grosso do Sul, two (1.6%) from the
adjoining state of Mato Grosso, and only one from the neighboring
state Rondônia. Ninety patients (73.2%) were born and lived lifelong
in Mato Grosso do Sul.
Clinical findings are summarized in Table 1, where the predominance
of neurological alterations was observed, followed by general and
respiratory manifestations. Cerebrospinal fluid (CSF) exam was
performed on 106 patients (90 HIV-infected and 16 noninfected). C.
neoformans was found in direct microscopy of India ink preparation in
93.4% (85/91) and in cultures of 80.2% (81/101). Histopathology of
lung (two cases) and prostate (one case) biopsies diagnosed the remaining
cases. The cytometry and biochemistry results are shown in Table 2.
In 77 cases it was possible to identify the Cryptococcus species:
69 (89.6%) cases of C. neoformans and eight (10.4%) of C. gattii.
Although five HIV-infected patients had cryptococcosis by C. gattii,
the infection by C. neoformans prevailed in both groups (HIV-infected
Table 1
Clinical manifestations of 123 cases of cryptococcosis, according to HIV co-infection. University Hospital, UFMS, Campo Grande, MS,
Brazil (Jan. 1995-Dec. 2005)
Clinical manifestation HIV-positive HIV-negative Total p
n = 104 % n = 19 % n = 123 %
General manifestations
Fever 73 70.9 14 73.7 87 71.3 NS
Weight loss 67 65.7 7 36.8 74 61.2 0.01
Neurological manifestations
Headache 82 79.6 11 57.9 93 76.2 0.03
Mental confusion 24 23.5 5 26.3 29 24.0 NS
Vomiting 63 61.2 10 52.6 73 59.8 NS
Motor deficit 6 5.8 0 0 6 4.9 NS
Visual alterations 24 23.1 5 26.3 29 23.6 NS
Neck stiffness 50 48.5 6 31.6 56 45.9 NS
Cutaneous manifestations
Skin lesions 1 1.0 0 0 1 0.8 NS
Respiratory manifestations
Cough 52 50.5 7 36.8 59 48.4 NS
NS: nonsignificant difference
Table 2
Cellularity and biochemical features of cerebrospinal fluid in 106 patients with
cryptococcosis, according to HIV co-infection. University Hospital, UFMS,
Campo Grande, MS, Brazil (Jan. 1995-Dec. 2005)
HIV-positive HIV-negative p
(n = 90) (n = 16)
Mean Median Mean Median
Leukocytes 64.3 6.5 207.4 119 0.00
(cells/mm3)
Proteins (mg/dL) 107.0 73.0 247.6 105 0.00
Glucose (mg/dL) 37.5 35.0 27.1 22 0.06
Fig. 1 - Distribution of 123 cases of cryptococcosis, with and without HIV co-infection, by
year of diagnosis. UFMS teaching hospital, Campo Grande, MS, Brazil, January 1995 to
December 2005.
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(60/65; 92.3%) and HIV-noninfected (9/12; 75%) patients (p > 0.05).
Most cases (90.2%) were treated with amphotericin B (106/123)
and fluconazole (57/123). 5-Flucytosine was associated with
amphotericin B in two cases and with itraconazole in one. The overall
lethality rate was 49.6%, reaching 51% among HIV-infected and 41.2%
among HIV-noninfected patients (p > 0.05).
DISCUSSION
This is the first clinical and epidemiological study of cryptococcosis
cases in Mato Grosso do Sul, where it predominates among HIV-
infected patients (84.6%), in agreement with the literature7-9. Among
the non-AIDS patients with cryptococcosis, nearly 50% had no obvious
predisposing factor10. The association of cryptococcosis with neoplastic
and lymphoproliferative disorders, and with the use of
immunosuppressive drugs, has been well established9,11,12.
Figure 1 shows that the distribution of cases by year before 2003
does not seem to follow any special patterns. The decreasing trend
observed since 2003 is possibly related to the use of combined
antiretroviral therapy.
As observed by others5,7,13, male patients predominated in our study.
In the recent AIDS era, cryptococcosis accompanies clearly the gender
distribution of HIV infection. Thus, the predominance of males reflects
the predisposing condition. Given the worldwide trend of feminization
of AIDS14, this situation is subject to changes. Similarly, the
predominance of cryptococcosis in the third and fourth decades of
life, in accordance with other studies5,13, coincides with the age range
where HIV is most prevalent.
The fact that most patients (73.2%) were from and lived lifelong
in the state of Mato Grosso do Sul suggests that the AIDS epidemic
has already hit the Center-Western Region of Brazil in an important
manner.
The most frequent clinical manifestations involved the central
nervous system and included headache and vomiting, in addition to
general symptoms such as fever and weight loss, are in agreement
with others7,13. The occurrence of fever was similar in both groups, but
the weight loss was more frequent among HIV carriers (p < 0.05), a
finding possibly related to the consumptive nature of AIDS. Headache
reported by 79.6% of HIV-infected patients was significantly more
frequent than the 57.9% reported by patients of the other group. In
contrast, visual alterations (blindness, visual impairment and double
vision) reported by 23.6% of all patients, were similarly distributed
between the groups, a result that agrees with the literature16.
Cutaneous manifestations were found only in HIV-infected patients,
resulting from hematogenous spread and increased immunologic
deficit3.
Since CSF cellularity and biochemical alterations are not specific,
differential diagnosis should consider principally tuberculous
meningoencephalitis13. Major CSF alterations were lymphocytic
pleocytosis, hyperproteinorrachia and hypoglycorrachia13, as observed
also in the present study. Significant differences were found in CSF
protein concentration and cellularity, with lower mean leukocyte counts
in the HIV-infected group. Of the HIV-infected patients, 45.6% had 5
leukocytes/mm3 or less, a finding that stresses the importance of
surveying fungi even when cytological parameters are normal. Other
investigators also report decreased inflammatory response in CSF in
patients with AIDS17.
The high sensitivity of direct microscopy of CSF with India ink
for detecting Cryptococcus spp. is well known9. Association with culture
on Sabouraud agar medium increases the likelihood of identifying these
fungi. Because C. neoformans and C. gattii usually cause
meningoencephalitis and because late diagnosis compromises
prognosis, search for capsulated yeasts in India ink and culture on
appropriate media should be part of routine procedures for every CSF
sample collected from patients suspected of central nervous system
inflammatory disease.
In cases of expansive masses, given the clinical and imaging
similarities with neoplasia, diagnosis usually is reached by
histopathological examination, as it occurred with three patients in the
present study. Besides, the importance of medical requests for
microbiological examination including surveys by direct microscopy
and cultures for fungi should be stressed. Through proper and careful
mycological processing of each clinical specimen it is not only possible
to confirm diagnosis, but also to identify the species.
In the present cases two rare occurrences were observed: one of
prostate mass involvement and one of fungemia concurrent with
Histoplasma capsulatum, as both fungi have been isolated from the
same blood samples.
C. gattii is likely to cause disease in healthy hosts (primary
pathogen)18, whereas C. neoformans attains predominantly
immunodepressed individuals12,19. Although AIDS associated
cryptococcosis by C. gattii has not been often reported, five of our
eight patients affected by this species also had HIV infection.
Antiretroviral therapy is intended to eliminate viral replication and
thus prevent devastation of the immune system, particularly of CD4+
lymphocytes. HIV-infected patients who are given combined
antiretroviral therapy have a lower incidence of cryptococcosis19.
Control of this opportunistic mycosis in patients with AIDS depends
therefore on the use of adequate antiretroviral treatment, with a resulting
improvement in the level of cellular immunodepression11-12.
RESUMO
Características clínicas e epidemiológicas de 123 casos de
criptococose observados em Mato Grosso do Sul, Brasil
O perfil clínico-epidemiológico de 123 casos de criptococose
diagnosticados no Hospital Universitário da Universidade Federal de
Mato Grosso do Sul, no período de janeiro de 1995 até dezembro de
2005, foi estudado retrospectivamente. Cento e quatro (84,9%) casos
tinham associação com HIV, seis (4,9%) tinham outra condição
predisponente e 13 (10,6%) eram imunocompetentes. Houve
predomínio do sexo masculino (68,3%) e a idade variou de 19 a 69
anos (média de 35,9 anos). A maioria (73,2%) era natural e procedente
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de Mato Grosso do Sul. O envolvimento do sistema nervoso central
ocorreu em 103 (83,7%) pacientes e os sintomas mais freqüentes foram
cefaléia e vômitos. Em 77 casos foi possível identificar a espécie do
agente, sendo 69 (89,6%) C. neoformans e oito (10,4%) C. gattii. O
antifúngico mais utilizado foi anfotericina B (106/123) seguido de
fluconazol em aproximadamente 60% dos casos. A taxa de letalidade
foi de 49,6%, sendo 51% entre os pacientes infectados pelo HIV e
41,2% entre os não infectados pelo HIV (p > 0,005). Apesar da
criptococose observada em nossa região apresentar comportamento
semelhante ao descrito na literatura, chama a atenção a importante
taxa da micose em imunocompetentes e cinco casos de infecção por
C. gattii em pacientes HIV-positivos.
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